The Medlines hosts go over trial data showing average weight loss of up to 28.3% at 80 weeks, alongside other medical news of the day.
Recap by typeshit. Post by @humancontentpods on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
Oral versions of drugs like Wegovy and Mounjaro are expected to win TGA approval soon, following the US and Europe, AFR reports.
Covers hair and nail findings, vision loss lawsuits Novo and Lilly dispute, and new WHO guidance against obesity drugs for kids under 10.
Loading…